Oxytocin MEG Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
SchizophreniaOxytocinMagnetoencephalography (MEG)Social Cognition
Interventions
DRUG

Oxytocin

40 IU of the oxytocin will be administered intranasally for a one time dose at the beginning of the visit.

DRUG

Saline Nasal Spray

40 IU of the saline nasal spray will be administered once at the beginning of the visit.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02568709 - Oxytocin MEG Study | Biotech Hunter | Biotech Hunter